From absurdity to reality: Medical device tax jolts Invacare CEO Malachi Mixon

By Mary Vanac

MedCity News logo

ELYRIA, Ohio — A. Malachi Mixon III shook his head when he first heard about a proposed $4 billion tax on medical device makers as part of the Senate Finance Committee’s healthcare reform bill last year.

“To be honest with you, when I first heard about this, I thought it was so absurd, it will never make it” into final reform legislation, said Mixon, chairman and CEO of Invacare Corp. (NYSE:IVC), which makes home healthcare products ranging from rehabilitative wheelchairs to oxygen systems.

But on Dec. 28, a modified version of the proposal did make it into the Senate’s healthcare reform bill. “All of a sudden, this thing passed. I couldn’t believe it. I can’t believe this is happening to our country,” he said.

Some device makers may be taking a wait-and-see approach when it comes to publicly disussing the proposed tax — it might not happen, they reason — but Mixon and Invacare are less reticent.

“We told our shareholders about the risks. I’m openly talking about it,” Mixon said.

Last week, Invacare said it expects to pay between $12 million and $14 million a year on U.S. sales of medical devices. To start saving money this year to pay that nut, Invacare has “already taken steps to suspend matching contributions under its 401(k) retirement plan, suspend merit pay increases for management employees and freeze new hiring,” according to a regulatory filing.

Mixon talked to MedCity News about the proposed tax and what it would mean for Invacare and the industry.

MedCity News: How do you describe the legislation in both the House and Senate that would tax U.S. sales of medical devices?

Invacare Corp. CEO Malachi Mixon

Malachi Mixon: The unfortunate thing about the tax is it is based on your sales, not on your profits. That means small companies with thin profit margins — or worse, losses — would pay proportionately more than large companies with decent margins.

For instance, Invacare lost money on its U.S. sales in 2008. The Senate tax is not deductible. In order to pay that tax, I would have had to make enough money to pay the federal tax, the state tax, the city tax, and then this new device tax.

MedCity News: What products made by Invacare are “medical devices?”

MM: All of our products are medical devices. Class 2 and Class 3 medical devices would be taxed under the proposed law. Invacare makes Class 1 (not taxed) and Class 2 devices. We don’t make any Class 3 devices like stents or heart valves.

MedCity News: The Senate’s version of the tax started at $4 billion a year. Now, it’s $2 billion a year. What happened?

MM: What we understand happened is very large companies through their association, AdvaMed, negotiated the tax down from $40 billion over 10 years to $20 billion. I wasn’t consulted. Our industry — home healthcare device makers — wasn’t consulted.

We belong to the Medical Device Manufacturing Assn., a small group of about 225 members. Our members’ profit margins average 3 percent — pretty thin.

MedCity News: In Washington, some are rationalizing the tax by saying companies that benefit from healthcare reform should help pay for reform. Do you agree?

MM: We’re not going to sell any more wheelchairs as a result of healthcare reform. Most of our patients are covered by the federal Medicare or Medicaid programs. The prices for their devices are set by the government. We don’t feel we benefit from reform. So I don’t feel we should pay $12-to-$14 million of tax on top of those we already do.

MedCity News: Invacare has suspended 401(k) account matches and merit pay, to start saving money to pay the tax. It’s also stopped hiring. What else might Invacare need to do to pay this tax?

MM: It’s a jump ball. We’re looking at everything. The last thing we want to do is have layoffs. But we’re looking at a price increases, moving our U.S. operations to lower-cost countries and cutting employee benefits and research and development spending.

MedCity News: Why are you speaking out about the tax, and what are you saying?

MM: I owe it to my shareholders to fight this thing to the end. If Invacare’s stock price suffers, so be it. I’m not doing any saber-rattling.

We’re talking about three things. We’re opposed to the tax, we don’t think it’s fair. Two, if there is to be a tax, it ought to be based on profits or gross margin, not on sales. Three, it ought to be delayed to give companies time to figure out how to pay the tax.

MedCity News: So Invacare was hiring before the tax was proposed? That must mean things were going pretty well.

MM: We’ve had our challenges. But we’ve grown from obscurity to the largest manufacturing company in Lorain County. We’re doing pretty well. Then this thing comes out of the blue.

This is not the way to pay for healthcare coverage for more people. Home healthcare device makers are the solution to the high cost of healthcare. We’re inventing devices that allow people to live longer lives, to live more cost-effectively at home. And to hurt us doesn’t make any sense.

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply